Aligos Therapeutics, Inc. (ALGS) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/07/24
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial ResultsGlobeNewsWire • 11/06/24
Aligos Therapeutics Appoints David Perry as Vice President of Business DevelopmentGlobeNewsWire • 10/01/24
Aligos Therapeutics Announces Positive Topline Results from the Phase 2a HERALD Study of ALG-055009 for the Treatment of MASHGlobeNewsWire • 09/19/24
Aligos Therapeutics to Announce Topline Results from the Phase 2a HERALD Study of ALG-055009 for the Treatment of MASH on September 19, 2024GlobeNewsWire • 09/18/24
How Much Upside is Left in Aligos Therapeutics (ALGS)? Wall Street Analysts Think 648.14%Zacks Investment Research • 08/21/24
Aligos Therapeutics Announces Clinical Collaboration with Xiamen Amoytop Biotech Co., Ltd.GlobeNewsWire • 07/22/24
Aligos Therapeutics to Host KOL Event to Discuss the Positive Phase 1b Data from ALG-000184 for the Treatment of CHBGlobeNewsWire • 07/10/24
Here's Why Aligos Therapeutics (ALGS) Is a Great 'Buy the Bottom' Stock NowZacks Investment Research • 06/04/24
Aligos Therapeutics Announces Six Abstracts Accepted for Presentation at EASL 2024GlobeNewsWire • 05/22/24
Aligos Therapeutics Announces the Completion of Enrollment in the ALG-055009 Phase 2a HERALD Study for the Treatment of MASHGlobeNewsWire • 05/21/24
After Plunging -13.71% in 4 Weeks, Here's Why the Trend Might Reverse for Aligos Therapeutics (ALGS)Zacks Investment Research • 05/16/24
Aligos Therapeutics to Announce 1st Quarter 2024 Financial Results on May 7, 2024GlobeNewsWire • 04/30/24
Aligos Therapeutics Presents Positive Clinical Data at ESCMID 2024 from the ALG-097558 Phase 1 StudyGlobeNewsWire • 04/25/24
Aligos Therapeutics, Inc. (ALGS) Just Flashed Golden Cross Signal: Do You Buy?Zacks Investment Research • 03/27/24
Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 StudiesGlobeNewsWire • 03/27/24
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial ResultsGlobeNewsWire • 03/12/24
Aligos Therapeutics to Announce 4th Quarter 2023 Financial Results on March 12, 2024GlobeNewsWire • 03/05/24
Aligos Therapeutics To Participate in the Leerink Partners Global Biopharma Conference 2024GlobeNewsWire • 02/26/24